Inlyta 5 MG tablet 60S
Ended Awarded Last action
- Contract number
- SPE2DR26F9KY9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,536
Award facts
- Contract value 100% obligated
- $12,536.26 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp (a subsidiary of Cencora, Inc.) on January 13, 2026, for the supply of INLYTA 5 mg tablets in quantities of 60 units. This is a firm fixed-price contract with a ceiling value of $12.5K and an ultimate completion date of February 4, 2026. The award represents a non-competitive delivery order executed under an existing contract vehicle, with performance to be fulfilled at the vendor's Conshohocken, Pennsylvania facility. INLYTA is an oncology medication used in the treatment of renal cell carcinoma, reflecting the Defense Logistics Agency's role in supplying specialized pharmaceutical products to military and veteran healthcare systems.
This delivery order is issued under AmerisourceBergen's substantial Indefinite Delivery Contract with the DLA Troop Support Medical (SPE2DX), valued at $999.99M through December 2026. As a critical pharmaceutical distributor for the federal government, AmerisourceBergen maintains comprehensive contracts to supply brand-name and generic medications, vaccines, and specialized medical commodities across multiple therapeutic domains to support military healthcare programs globally. The non-set-aside designation indicates this order was competitively awarded through the broader federal procurement process, leveraging the vendor's established capability to meet government medical supply requirements efficiently.
Quick answers
Who was awarded contract SPE2DR26F9KY9?
SPE2DR26F9KY9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 13, 2026.
How much is contract SPE2DR26F9KY9 worth?
The government has obligated $12,536 on SPE2DR26F9KY9.
Is contract SPE2DR26F9KY9 an order under another contract?
Yes. SPE2DR26F9KY9 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9KY9 competed?
The extent of competition for SPE2DR26F9KY9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award